Laurie Toich, Assistant Editor

Increased safety warnings issued for using opioids and benzodiazepines together.

Antibody prevents blood clots and excessive bleeding to improve treatment of atrial fibrillation.

Pinpointing opioid hot spots can create targeted prevention and treatment efforts.

Cells in the lung that exacerbate the immune response contribute to asthma attacks.

Top news of the day from across the healthcare landscape.

New method can quickly and effectively diagnose infections with a small amount of blood.

Physically aging a participant’s face may lead to lower long-term healthcare costs.

Pharmacy benefit manager alliance with retail pharmacy giant Walgreens is the first of its kind.

The American Journal of Pharmacy Benefits speaks with Prime Therapeutics President and CEO on the strategic alliance with retail pharmacy giant Walgreens.

Drugs that treat diabetes are prescribed significantly more than antiobesity medications.

Morphine tolerance found to be caused by an inflammatory response in the brain.

Sonoporation selectively opens cells and allows targeted drugs to be delivered inside the cell.

Factors other than race or ethnicity influence outcomes in multiple myeloma.

Top news of the day from across the healthcare landscape.

Over half a million people have enrolled in New Jersey’s Medicaid program since expansion 2014.

The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow, will allow pharmacists to obtain continuing education credits while staying on top of the latest oncology advances.

The Centers for Medicare and Medicaid Services takes action to improve Affordable Care Act exchanges.

Erelzi, an etanercept biosimilar, was approved for rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis.

Pharmacokinetics of tecarfarin were not compromised by renal function like it was with warfarin.

Campaigns for Proposition 61 have gained major funding from critics and supporters of the law.

Sandoz has gained FDA-approval for Erelzi, an etanercept biosimilar.

SGLT2 inhibitors can lower blood glucose levels and potentially protect the kidneys.

Regenerative bandage could reduce amputations and poor health outcomes from diabetic sores.

Top news of the day from across the healthcare landscape.

Duration and degree of being overweight impacts cancer risk in postmenopausal women.

Achievements made among the many aspects of healthcare insurance are explored.

The CMS reveals Medicare Part D prescription drug costs for the second year in a row.

This is the first sickle cell disease treatment created in 20 years.

Flavanone consumption associated with lower levels of cell-damage markers.

Genes related to eye color may cause cancer of the eye.